Inhalants: The Substance Class Nobody Talks About

Body — 8 lenses: [Science: solvents act as NMDA antagonists + GABA modulators; nitrites as smooth-muscle relaxants via NO; aerosols variable. Biology: sudden sniffing death syndrome (cardiac sensitization to catecholamines), hypoxia, leukoencephalopathy (toluene), hepatorenal toxicity. Psychology: typically first-used age 9–13, often precedes other substance use; associated with ACEs. Policy: mostly not controlled (volatile solvents legal); age-of-sale laws for specific products; poppers under ambiguous FDA status. Trends: SAMHSA NSDUH tracks; resurgence concerns in some regions. Social: historically framed as “kid’s drug”; underrepresented in most SUD curricula. Treatment: abstinence-based (no meds); family therapy; CRAFT. Harm reduction: never use alone, ventilation, don’t use with CNS depressants, education for parents and schools.]